Latest market price
71.78
-1.87-2.54%
OverviewShort InterestFilings
INBXQT15Inhibrx Biosciences Inc.·NASDAQ
71.78-2.54%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 14, 20264Statement of changes in beneficial ownership
Sep 28, 20268-KCurrent report
Sep 28, 20264Statement of changes in beneficial ownership
Sep 23, 20264Statement of changes in beneficial ownership
Sep 18, 20264/AStatement of changes in beneficial ownership (amended)
Sep 18, 20264/AStatement of changes in beneficial ownership (amended)
Sep 18, 20264/AStatement of changes in beneficial ownership (amended)
Sep 18, 20264/AStatement of changes in beneficial ownership (amended)
Sep 17, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 2026144Notice of proposed sale of restricted securities
Sep 14, 2026144Notice of proposed sale of restricted securities
Sep 11, 2026144Notice of proposed sale of restricted securities
Sep 10, 20264Statement of changes in beneficial ownership
Sep 09, 2026144Notice of proposed sale of restricted securities
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 08, 2026144Notice of proposed sale of restricted securities
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 20268-KCurrent report
#1 / 25 of 320
Page
▼
/ 13